Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use

Table of Contents

CHAPTER 1 MARKET OVERVIEW

• 1.1 Market Definition and Segment
  • 1.1.1 Product Definition
  • 1.1.2 Product Type
  • 1.1.3 End-Use
  • 1.1.4 Marketing Channel
• 1.2 Major Regions
  • 1.2.1 Europe Market Size and Growth

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD)

• 1.2.2 America Market Size and Growth

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD)

• 1.2.3 Asia Market Size and Growth

Figure Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure AsiaCastration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD)

• 1.2.4 Oceania Market Size and Growth

Figure Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD)

• 1.2.5 Africa Market Size and Growth

Figure Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

• 2.1 Global Production Overview

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 2.2 Global Consumption Overview

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 2.3 Global Production by Type

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Type in 2020 (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume Share by Type in 2020 (Volume)

• 2.4 Global Consumption by End-Use

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value Share by End-Use in 2020 (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume Share by End-Use in 2020 (Volume)

• 2.5 Global Consumption by Region

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 Europe MARKET SEGMENTATION

• 3.1 Europe Production Overview

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 3.2 Europe Consumption Overview

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 3.3 Europe Production by Type

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Type in 2020 (Million USD)

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume Share by Type in 2020 (Volume)

• 3.4 Europe Consumption by End-Use

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value Share by End-Use in 2020 (Million USD)

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume Share by End-Use in 2020 (Volume)

• 3.5 Europe Consumption by Region

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

• 4.1 America Production Overview

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 4.2 America Consumption Overview

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 4.3 America Production by Type

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Type in 2020 (Million USD)

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume Share by Type in 2020 (Volume)

• 4.4 America Consumption by End-Use

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value Share by End-Use in 2020 (Million USD)

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume Share by End-Use in 2020 (Volume)

• 4.5 America Consumption by Region

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

• 5.1 Asia Production Overview

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 5.2 Asia Consumption Overview

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 5.3 Asia Production by Type

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Figure Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Type in 2020 (Million USD)

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Figure Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume Share by Type in 2020 (Volume)

• 5.4 Asia Consumption by End-Use

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Figure Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value Share by End-Use in 2020 (Million USD)

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Figure Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume Share by End-Use in 2020 (Volume)

• 5.5 Asia Consumption by Region

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

• 6.1 Oceania Production Overview

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 6.2 Oceania Consumption Overview

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 6.3 Oceania Production by Type

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Figure Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Type in 2020 (Million USD)

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Figure Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume Share by Type in 2020 (Volume)

• 6.4 Oceania Consumption by End-Use

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Figure Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value Share by End-Use in 2020 (Million USD)

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Figure Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume Share by End-Use in 2020 (Volume)

• 6.5 Oceania Consumption by Region

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

• 7.1 Africa Production Overview

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

• 7.2 Africa Consumption Overview

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

• 7.3 Africa Production by Type

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Figure Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Type in 2020 (Million USD)

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Figure Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume Share by Type in 2020 (Volume)

• 7.4 Africa Consumption by End-Use

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Figure Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value Share by End-Use in 2020 (Million USD)

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Figure Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume Share by End-Use in 2020 (Volume)

• 7.5 Africa Consumption by Region

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

• 8.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Forecast

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Growth Rate Forecast 2020E-2025F (Million USD)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume and Growth Rate Forecast 2020E-2025F (Volume)

• 8.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecast by Type

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2020E-2025F (Million USD)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Type in 2025 (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2020E-2025F (Volume)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume Share by Type in 2025 (Volume)

• 8.3 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecast by End-Use (2020E-2025F)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2020E-2025F (Million USD)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value Share by End-Use in 2025 (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2020E-2025F (Volume)

• 8.4 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecast by Region (2020E-2025F)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2020E-2025F (Million USD)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value Share by Region in 2025 (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2020E-2025F (Volume)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

• 9.1 Astellas
  • 9.1.1 Astellas Profile

Table Astellas Overview List

• 9.1.2 Astellas Products & Services
• 9.1.3 Astellas Company Dynamics & News
• 9.1.4 Astellas Business Operation Conditions

Table Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.2 Johnson & Johnson
  • 9.2.1 Johnson & Johnson Profile

Table Johnson & Johnson Overview List

• 9.2.2 Johnson & Johnson Products & Services
• 9.2.3 Johnson & Johnson Company Dynamics & News
• 9.2.4 Johnson & Johnson Business Operation Conditions

Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.3 Sanofi
  • 9.3.1 Sanofi Profile

Table Sanofi Overview List

• 9.3.2 Sanofi Products & Services
• 9.3.3 Sanofi Company Dynamics & News
• 9.3.4 Sanofi Business Operation Conditions

Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.4 Dendreon.
  • 9.4.1 Dendreon. Profile

Table Dendreon. Overview List

• 9.4.2 Dendreon. Products & Services
• 9.4.3 Dendreon. Company Dynamics & News
• 9.4.4 Dendreon. Business Operation Conditions

Table Business Operation of Dendreon. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 9.5 Bayer
  • 9.5.1 Bayer Profile

Table Bayer Overview List

• 9.5.2 Bayer Products & Services
• 9.5.3 Bayer Company Dynamics & News
• 9.5.4 Bayer Business Operation Conditions

Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

PART 10 MARKET COMPETITION

• 10.1 Key Company Market Share

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales Revenue 2015-2020E, by Companies, in USD Million

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales Revenue Share, 2015-2020E, by Companies, in USD

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales Volume by Companies, 2015-2020E (Volume)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales Volume Share by Companies, 2015-2020E (Volume)

• 10.2 Regional Market Concentration

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio in 2020E

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio in 2020E

Figure Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio in 2020E

Figure Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio in 2020E

Figure Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics INDUSTRY

• 11.1 Impact on Industry Upstream
• 11.2 Impact on Industry Downstream
• 11.3 Impact on Industry Channels
• 11.4 Impact on Industry Competition
• 11.5 Impact on Industry Obtain Employment

PART 12 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics INDUSTRY SUMMARY & CONCLUSION

List of Table

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2015-2020 (Million USD)

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2015-2020 (Volume)

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD)

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume)

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2015-2020 (Million USD)

Table Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2015-2020 (Volume)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Type, 2020E-2025F (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume by Type, 2020E-2025F (Volume)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by End-Use, 2020E-2025F (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by End-Use, 2020E-2025F (Volume)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value by Region, 2020E-2025F (Million USD)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume by Region, 2020E-2025F (Volume)

Table Astellas Overview List

Table Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dendreon. Overview List

Table Business Operation of Dendreon. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer Overview List

Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales Revenue 2015-2020E, by Companies, in USD Million

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales Revenue Share, 2015-2020E, by Companies, in USD

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales Volume by Companies, 2015-2020E (Volume)

Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Sales Volume Share by Companies, 2015-2020E (Volume)

List of Figure

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD)

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD)

Figure Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure AsiaCastration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD)

Figure Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure Oceania Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD)

Figure Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD)

Figure Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Type in 2020 (Million USD)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume Share by Type in 2020 (Volume)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value Share by End-Use in 2020 (Million USD)

Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume Share by End-Use in 2020 (Volume)

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Type in 2020 (Million USD)

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume Share by Type in 2020 (Volume)

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value Share by End-Use in 2020 (Million USD)

Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume Share by End-Use in 2020 (Volume)

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Type in 2020 (Million USD)

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume Share by Type in 2020 (Volume)

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Value Share by End-Use in 2020 (Million USD)

Figure America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Consumption Volume Share by End-Use in 2020 (Volume)

Figure Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Share by Type in 2020 (Million USD)

Figure Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Production Volume Share by Type in 2020 (Volume)

Figure Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA